Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05245695 · ClinicalTrials.gov registry record

Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)

A clinical trial of Endometriosis, sponsored by Aspira Women's Health.

Recruiting
Registry status
1,200
Enrollment target
10
Study locations

NCT05245695 is a study of Endometriosis that is actively recruiting participants, run by Aspira Women's Health. The registered enrollment target is 1,200 participants, above the 239-participant average among 48 other Endometriosis trials with a reported enrollment target (402% higher). The trial reports 10 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05245695, a study of Endometriosis, is actively recruiting participants, sponsored by Aspira Women's Health.

RECRUITING
Registry status
1,200 participants
Enrollment target
10
Study locations

Study Summary

The goal of this observational study is to determine the clinical validity of a deep neural network algorithm that utilizes protein biomarker detection of Endometriosis - "EndoCheck" - as an "aid in diagnosis" for endometriosis and to show validity as a diagnostic test

Conditions Studied

Endometriosis

Interventions

  • OTHER Observational study, no intervention

Study Locations (10)

Arizona

  • New Horizons Clinical Trials - Chandler

California

  • Velvet Clinical Research - Burbank

Delaware

  • Reproductive Associates of Delaware (RAD) - Newark

Georgia

  • Midtown OBGYN North - Columbus

Indiana

  • Cindy Basinski, MD - Forest Hill

Maryland

  • Johns Hopkins School of Medicine - Baltimore

New York

  • Nezhat Surgery for Gynecology/Oncology - Valley Stream

Ohio

  • Seven Hills Clinical Research - Cincinnati

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2022-07-12
Est. Completion 2026-06-30

Sponsor

Aspira Women's Health

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05245695

The ClinicalTrials.gov registry entry for NCT05245695 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 239-participant average among 48 other Endometriosis trials with a reported enrollment target (402% higher). The listed sponsor is Aspira Women's Health, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 1 intervention - of which Observational study, no intervention is the first listed.

NCT05245695 reports 10 study locations spanning 10 distinct geographic areas - top geographies include Arizona, California, Delaware.

Frequently Asked Questions

What is clinical trial NCT05245695 about?

NCT05245695 is a clinical study titled "Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)". The goal of this observational study is to determine the clinical validity of a deep neural network algorithm that utilizes protein biomarker detection of Endometriosis - "EndoCheck" - as an "aid in diagnosis" for endometriosis and to show validity as a diagnostic test

What is the current status of trial NCT05245695?

This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2022-07-12. Estimated completion is 2026-06-30.

What conditions does trial NCT05245695 study?

This clinical trial studies the following conditions: Endometriosis.

What interventions are being tested in trial NCT05245695?

The interventions under investigation include: Observational study, no intervention (OTHER).

Who is sponsoring clinical trial NCT05245695?

This trial is sponsored by Aspira Women's Health, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05245695 being conducted?

This trial has 10 study locations across Arizona, California, Delaware, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Endometriosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Endometriosis

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.